These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33060829)

  • 1. Central aortic pressure and long-term outcome in hypertensive patients undergoing percutaneous coronary intervention.
    Wu HP; Lin MJ
    Sci Rep; 2020 Oct; 10(1):17420. PubMed ID: 33060829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Central Pulse Pressure for Mortality in Patients With Coronary Artery Disease Receiving Repeated Percutaneous Coronary Intervention.
    Lin MJ; Chen CY; Lin HD; Lin CS; Wu HP
    Medicine (Baltimore); 2016 Mar; 95(13):e3218. PubMed ID: 27043689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Pre-Procedural Blood Pressure on Long-Term Outcomes Following Percutaneous Coronary Intervention.
    Warren J; Nanayakkara S; Andrianopoulos N; Brennan A; Dinh D; Yudi M; Clark D; Ajani AE; Reid CM; Selkrig L; Shaw J; Hiew C; Freeman M; Kaye D; Kingwell BA; Dart AM; Duffy SJ;
    J Am Coll Cardiol; 2019 Jun; 73(22):2846-2855. PubMed ID: 31171090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U-shaped association of central pulse pressure with long-term prognosis after ST-segment elevation myocardial infarction.
    Ndrepepa G; Cassese S; Kufner S; Xhepa E; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
    Heart Vessels; 2019 Jul; 34(7):1104-1112. PubMed ID: 30671640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation Between Smoking Paradox and Heart Rhythm Outcomes in Patients With Coronary Artery Disease Receiving Percutaneous Coronary Intervention.
    Wu HP; Jan SL; Chang SL; Huang CC; Lin MJ
    Front Cardiovasc Med; 2022; 9():803650. PubMed ID: 35224045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and chronic kidney disease affect long-term outcomes in patients with stable coronary artery disease receiving percutaneous coronary intervention.
    Lin MJ; Yang WC; Chen CY; Huang CC; Chuang HY; Gao FX; Wu HP
    Sci Rep; 2018 Dec; 8(1):17673. PubMed ID: 30518771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central aortic pressure improves prediction of cardiovascular events compared to peripheral blood pressure in short-term follow-up of a hypertensive cohort.
    Zuo J; Chang G; Tan I; Butlin M; Chu SL; Avolio A
    Clin Exp Hypertens; 2020; 42(1):16-23. PubMed ID: 30554536
    [No Abstract]   [Full Text] [Related]  

  • 9. Visit-to-visit variability of systolic blood pressure predicts all-cause mortality in patients received percutaneous coronary intervention with drug-eluting stents.
    Seo SM; Chung WB; Choi IJ; Koh YS; Ihm SH; Kim PJ; Chung WS; Seung KB
    Heart Vessels; 2018 May; 33(5):489-497. PubMed ID: 29151154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study.
    Wang HT; Chen YL; Wu CJ
    Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental Prognostic Value of Post-Intervention Pd/Pa in Patients Undergoing Ischemia-Driven Percutaneous Coronary Intervention.
    Hakeem A; Ghosh B; Shah K; Agarwal S; Kasula S; Hacioglu Y; Bhatti S; Ahmed Z; Uretsky B
    JACC Cardiovasc Interv; 2019 Oct; 12(20):2002-2014. PubMed ID: 31648762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Analysis for Cardiogenic Shock in Patients with Acute Myocardial Infarction Receiving Percutaneous Coronary Intervention.
    Lin MJ; Chen CY; Lin HD; Wu HP
    Biomed Res Int; 2017; 2017():8530539. PubMed ID: 28251160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of central pulse pressure with contrast-induced nephropathy and clinical outcomes in patients undergoing coronary intervention.
    Huang SS; Huang PH; Leu HB; Wu TC; Lin SJ; Chen JW
    J Hypertens; 2013 Nov; 31(11):2187-94. PubMed ID: 23868087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct survival benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers in revascularized coronary artery disease patients according to history of myocardial infarction.
    Nishino T; Furukawa Y; Kaji S; Ehara N; Shiomi H; Kim K; Kitai T; Kinoshita M; Morimoto T; Sakata R; Kimura T;
    Circ J; 2013; 77(5):1242-52. PubMed ID: 23291989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic stiffness affects the coronary blood flow response to percutaneous coronary intervention.
    Leung MC; Meredith IT; Cameron JD
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H624-30. PubMed ID: 16143654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.